| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
Form 4: Cannon-Brookes Michael, Director
Bought 13,400 shares ($2M) |
| 13 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 |
Form 4: Cannon-Brookes Michael, Director
Bought 13,400 shares ($2.01M) |
| 06 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
Remaining performance obligations of $4,746 million, up 44% year-over-year |
| 15 Oct 2026 | 144 |
| 14 Oct 2026 | ARS |
| 14 Oct 2026 | DEFA14A |
| 14 Oct 2026 |
Proxy statement: annual meeting on December 1, 2026
CEO pay $57K, up 5.7% · say-on-pay vote |
| 13 Oct 2026 |
Form 4: Liu Gene, Chief Accounting Officer
Sold 337 shares ($70.8K) |
| 13 Oct 2026 | 144 |
| 22 Sep 2026 |
Form 4: Duffy Brian, Chief Revenue Officer
Received 51,549 shares as a grant or award |
| 22 Sep 2026 |
Form 4: Chuong James, Chief Financial Officer
Received 6,374 shares as a grant or award |
| 31 Aug 2026 |
Form 4: Liu Gene, Chief Accounting Officer
Sold 939 shares ($178K) |
| 27 Aug 2026 | 144 |
| 20 Aug 2026 |
Form 4: Chuong James, Chief Financial Officer
Sold 9,054 shares ($1.56M) |
| 20 Aug 2026 |
Form 4: Duffy Brian, Chief Revenue Officer
Sold 1,851 shares ($319K) |
| 20 Aug 2026 |
Form 4: Liu Gene, Chief Accounting Officer
Sold 1,125 shares ($197K) |
| 19 Aug 2026 | 144 |
| 19 Aug 2026 | 144 |
Loading...